Delivery Order SPE2DR25D1202-SPE2DR26F73GM
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $7.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,854.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mitomycin 20 mg vials, with an ultimate completion date of December 17, 2025. This is an unset-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,146.40 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mitomycin 5 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,578.48 for Mitomycin 20 mg vials on November 25, 2025, with an ultimate completion date of November 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric and oncology pharmaceutical product sourced through the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,269.84 to AmerisourceBergen Drug Corp for the supply of Mylotarg 4.5 mg vials. This firm fixed-price, competitive delivery order was issued on November 13, 2025, with an ultimate completion date of December 5, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects the vendor's demonstrated capability to meet...
- This delivery order, valued at $14,528.80 and awarded September 3, 2025, represents a competitive procurement by the Defense Logistics Agency (DLA) for MENQUADFI vials (0.5mL) from AmerisourceBergen Drug Corp, the primary pharmaceutical distributor for federal military and healthcare systems. The award is non-set-aside and utilizes firm fixed-price pricing, with completion scheduled for September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,038.61 to AmerisourceBergen Drug Corp on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $16,208.20 delivery order contract (4570030738) to AmerisourceBergen Drug Corp on November 17, 2025, for pharmaceutical products and related medical supplies. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, represents a competitive award with no set-aside designation. The place of performance...
- The Defense Logistics Agency awarded a $8,173.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 microgram vials of dactinomycin, an antitumor antibiotic used in cancer chemotherapy. The award, made on December 4, 2025, with an ultimate completion date of December 5, 2025, is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $40,227 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...